Industry: Service & Software
Published Date: 2024-02-21
Pages: 111 Pages
Report ld: 2543372
Request Sample
Customized Report
Declining follicular pool and oocyte quality specially in the mid to late thirties.
This age-related decline of follicles in the human ovary is supposed to be more than double when numbers fall below a critical figure of 25,000 at ~37.5 years of age. According to World Health Organization (WHO), the number of women age 60 and over will increase from about 336 million in 2000 to just over 1 billion in 2050.
Moreover, safety and efficacy associated with ovarian reserve tests is likely to increase the demand in the near future. Manufacturers are also developing home testing kits for ovarian reserve test also provides easy accessibility and availability for checkups which is likely to rise the demand.
Ovarian surgeries also play an important role in driving the market, since removal of cysts can also result in diminished ovarian follicle in women. Thus, all these factors are likely to increase the market growth in the forecast period.
The global market for Ovarian Reserve Test was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Ovarian Reserve Test was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ovarian Reserve Test was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Ovarian Reserve Test was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Ovarian Reserve Test include Beckman Coulter, Fujirebio, F. Hoffmann-La Roche Ltd, Everlywell, LabCorp, VIDAS, Modern Fertility, Future Family and LetsGetChecked, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Ovarian Reserve Test, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Ovarian Reserve Test by region & country, by Type, and by Application.
The Ovarian Reserve Test market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ovarian Reserve Test.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ovarian Reserve Test manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Ovarian Reserve Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Ovarian Reserve Test in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Ovarian Reserve Test Product Introduction
1.2 Global Ovarian Reserve Test Market Size Forecast
1.3 Ovarian Reserve Test Market Trends & Drivers
1.3.1 Ovarian Reserve Test Industry Trends
1.3.2 Ovarian Reserve Test Market Drivers & Opportunity
1.3.3 Ovarian Reserve Test Market Challenges
1.3.4 Ovarian Reserve Test Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ovarian Reserve Test Players Revenue Ranking (2023)
2.2 Global Ovarian Reserve Test Revenue by Company (2019-2024)
2.3 Key Companies Ovarian Reserve Test Manufacturing Base Distribution and Headquarters
2.4 Key Companies Ovarian Reserve Test Product Offered
2.5 Key Companies Time to Begin Mass Production of Ovarian Reserve Test
2.6 Ovarian Reserve Test Market Competitive Analysis
2.6.1 Ovarian Reserve Test Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Ovarian Reserve Test Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Reserve Test as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Follicle Stimulating Hormone (FSH) Testing
3.1.2 Anti-Mullerian hormone (AMH) Testing
3.1.3 Antral Follicle Count Testing
3.1.4 Basal Follicle Stimulating Hormone Testing
3.2 Global Ovarian Reserve Test Sales Value by Type
3.2.1 Global Ovarian Reserve Test Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Ovarian Reserve Test Sales Value, by Type (2019-2030)
3.2.3 Global Ovarian Reserve Test Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 IVF Centers
4.1.3 Diagnostic Centres
4.1.4 Ambulatory Surgical Centres
4.1.5 Others
4.2 Global Ovarian Reserve Test Sales Value by Application
4.2.1 Global Ovarian Reserve Test Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Ovarian Reserve Test Sales Value, by Application (2019-2030)
4.2.3 Global Ovarian Reserve Test Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Ovarian Reserve Test Sales Value by Region
5.1.1 Global Ovarian Reserve Test Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Ovarian Reserve Test Sales Value by Region (2019-2024)
5.1.3 Global Ovarian Reserve Test Sales Value by Region (2025-2030)
5.1.4 Global Ovarian Reserve Test Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Ovarian Reserve Test Sales Value, 2019-2030
5.2.2 North America Ovarian Reserve Test Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Ovarian Reserve Test Sales Value, 2019-2030
5.3.2 Europe Ovarian Reserve Test Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Ovarian Reserve Test Sales Value, 2019-2030
5.4.2 Asia Pacific Ovarian Reserve Test Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Ovarian Reserve Test Sales Value, 2019-2030
5.5.2 South America Ovarian Reserve Test Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Ovarian Reserve Test Sales Value, 2019-2030
5.6.2 Middle East & Africa Ovarian Reserve Test Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ovarian Reserve Test Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Ovarian Reserve Test Sales Value
6.3 United States
6.3.1 United States Ovarian Reserve Test Sales Value, 2019-2030
6.3.2 United States Ovarian Reserve Test Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Ovarian Reserve Test Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Ovarian Reserve Test Sales Value, 2019-2030
6.4.2 Europe Ovarian Reserve Test Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Ovarian Reserve Test Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Ovarian Reserve Test Sales Value, 2019-2030
6.5.2 China Ovarian Reserve Test Sales Value by Type (%), 2023 VS 2030
6.5.3 China Ovarian Reserve Test Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Ovarian Reserve Test Sales Value, 2019-2030
6.6.2 Japan Ovarian Reserve Test Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Ovarian Reserve Test Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Ovarian Reserve Test Sales Value, 2019-2030
6.7.2 South Korea Ovarian Reserve Test Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Ovarian Reserve Test Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Ovarian Reserve Test Sales Value, 2019-2030
6.8.2 Southeast Asia Ovarian Reserve Test Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Ovarian Reserve Test Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Ovarian Reserve Test Sales Value, 2019-2030
6.9.2 India Ovarian Reserve Test Sales Value by Type (%), 2023 VS 2030
6.9.3 India Ovarian Reserve Test Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Beckman Coulter
7.1.1 Beckman Coulter Profile
7.1.2 Beckman Coulter Main Business
7.1.3 Beckman Coulter Ovarian Reserve Test Products, Services and Solutions
7.1.4 Beckman Coulter Ovarian Reserve Test Revenue (US$ Million) & (2019-2024)
7.1.5 Beckman Coulter Recent Developments
7.2 Fujirebio
7.2.1 Fujirebio Profile
7.2.2 Fujirebio Main Business
7.2.3 Fujirebio Ovarian Reserve Test Products, Services and Solutions
7.2.4 Fujirebio Ovarian Reserve Test Revenue (US$ Million) & (2019-2024)
7.2.5 Fujirebio Recent Developments
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Profile
7.3.2 F. Hoffmann-La Roche Ltd Main Business
7.3.3 F. Hoffmann-La Roche Ltd Ovarian Reserve Test Products, Services and Solutions
7.3.4 F. Hoffmann-La Roche Ltd Ovarian Reserve Test Revenue (US$ Million) & (2019-2024)
7.3.5 Everlywell Recent Developments
7.4 Everlywell
7.4.1 Everlywell Profile
7.4.2 Everlywell Main Business
7.4.3 Everlywell Ovarian Reserve Test Products, Services and Solutions
7.4.4 Everlywell Ovarian Reserve Test Revenue (US$ Million) & (2019-2024)
7.4.5 Everlywell Recent Developments
7.5 LabCorp
7.5.1 LabCorp Profile
7.5.2 LabCorp Main Business
7.5.3 LabCorp Ovarian Reserve Test Products, Services and Solutions
7.5.4 LabCorp Ovarian Reserve Test Revenue (US$ Million) & (2019-2024)
7.5.5 LabCorp Recent Developments
7.6 VIDAS
7.6.1 VIDAS Profile
7.6.2 VIDAS Main Business
7.6.3 VIDAS Ovarian Reserve Test Products, Services and Solutions
7.6.4 VIDAS Ovarian Reserve Test Revenue (US$ Million) & (2019-2024)
7.6.5 VIDAS Recent Developments
7.7 Modern Fertility
7.7.1 Modern Fertility Profile
7.7.2 Modern Fertility Main Business
7.7.3 Modern Fertility Ovarian Reserve Test Products, Services and Solutions
7.7.4 Modern Fertility Ovarian Reserve Test Revenue (US$ Million) & (2019-2024)
7.7.5 Modern Fertility Recent Developments
7.8 Future Family
7.8.1 Future Family Profile
7.8.2 Future Family Main Business
7.8.3 Future Family Ovarian Reserve Test Products, Services and Solutions
7.8.4 Future Family Ovarian Reserve Test Revenue (US$ Million) & (2019-2024)
7.8.5 Future Family Recent Developments
7.9 LetsGetChecked
7.9.1 LetsGetChecked Profile
7.9.2 LetsGetChecked Main Business
7.9.3 LetsGetChecked Ovarian Reserve Test Products, Services and Solutions
7.9.4 LetsGetChecked Ovarian Reserve Test Revenue (US$ Million) & (2019-2024)
7.9.5 LetsGetChecked Recent Developments
7.10 EggQ
7.10.1 EggQ Profile
7.10.2 EggQ Main Business
7.10.3 EggQ Ovarian Reserve Test Products, Services and Solutions
7.10.4 EggQ Ovarian Reserve Test Revenue (US$ Million) & (2019-2024)
7.10.5 EggQ Recent Developments
8 Industry Chain Analysis
8.1 Ovarian Reserve Test Industrial Chain
8.2 Ovarian Reserve Test Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ovarian Reserve Test Sales Model
8.5.2 Sales Channel
8.5.3 Ovarian Reserve Test Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Ovarian Reserve Test was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 110
USD 3950.00
(Single User License)
The global Ovarian Reserve Test market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 103
USD 2900.00
(Single User License)
The global Ovarian Reserve Test market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 120
USD 4900.00
(Single User License)
The global market for Ovarian Reserve Test was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 99
USD 3950.00
(Single User License)
The global market for Ovarian Reserve Test was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 73
USD 2900.00
(Single User License)
Declining follicular pool and oocyte quality specially in the mid to late thirties.
Published Date: 2024-04-16
Pages: 112
USD 4900.00
(Single User License)
Declining follicular pool and oocyte quality specially in the mid to late thirties.
Published Date: 2024-01-08
Pages: 84
USD 2900.00
(Single User License)
The global market for Ovarian Reserve Test was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 110
The global Ovarian Reserve Test market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 103
The global Ovarian Reserve Test market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 120
The global market for Ovarian Reserve Test was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 99
The global market for Ovarian Reserve Test was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 73
Declining follicular pool and oocyte quality specially in the mid to late thirties.
Published: 2024-04-16
Pages: 112
Declining follicular pool and oocyte quality specially in the mid to late thirties.
Published: 2024-01-08
Pages: 84
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now